spironolactone and semaglutide + Semaglutide: Safety & Drug Interaction Guide – PlexusDx Finerenone Finally Finishing off Spironolactone?

Peer-reviewed clinical trial data published in the New England Journal of Medicine establishing semaglutides efficacy for chronic weight management, with average weight loss of 14.9 percent of body weight at 68 weeks positions these as a fundamentally different category of intervention than peptides like GHK-Cu

Detailed TRIUMPH-1 data is expected to be presented at the 86th American Diabetes Association Scientific Sessions later in 2026

Once the foundation of hospital inpatient revenue, many high-margin surgical procedures are likely to face growing competition from minimally invasive procedures and medications

If you are experiencing bothersome nausea, request to remain at your current dose for an additional week or two before titrating up, giving your body more time to acclimate